Literature DB >> 27455401

Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants.

Lee A Denson1, Scott A McDonald2, Abhik Das2, Diana E Schendel3, Kristin Skogstrand4, David M Hougaard4, Seetha Shankaran5, Rosemary D Higgins6, Waldemar A Carlo7, Richard A Ehrenkranz8.   

Abstract

Objective To determine whether reduced growth velocity (GV) in extremely low birth weight infants is preceded by elevated inflammatory cytokines. Study Design GV was determined at 36 weeks' postmenstrual age (PMA) in 768 infants 401 to 1,000 g birth weight (BW). Association between blood cytokines measured through day of life 21 and GV was explored using linear regression models that adjusted for late-onset sepsis (LOS), BW, small for gestational age (SGA), gender, race, energy intake, and center. Results Serum interleukin-6 (IL-6) was increased at days 14 and 21 in LOS infants. LOS was associated with reduced energy intake and GV for weight (weight-GV) at 36 weeks' PMA. Linear regression analysis controlling for LOS and energy intake showed significant relationships between increased IL-6 at days 14 and 21 with reduced weight-GV at 36 weeks' PMA (p < 0.0001). The relationship between day 21 IL-6 and weight-GV was not associated with LOS (p = 0.12) when controlling for BW and energy intake. Both BW (p = 0.02) and energy intake (p = 0.003) influenced the relationship between day 14 IL-6 and weight-GV. Conclusion IL-6 elevation during the first month of life is associated with lower weight-GV at 36 weeks' PMA and may have a direct effect upon energy balance and postnatal growth. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27455401      PMCID: PMC5296404          DOI: 10.1055/s-0036-1585419

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  28 in total

1.  The Impact of Neonatal Illness on Nutritional Requirements-One Size Does Not Fit All.

Authors:  Sara E Ramel; Laura D Brown; Michael K Georgieff
Journal:  Curr Pediatr Rep       Date:  2014-12

2.  Growth restriction in dexamethasone-treated preterm infants may be mediated by reduced IGF-I and IGFBP-3 plasma concentrations.

Authors:  F H Bloomfield; D B Knight; B H Breier; J E Harding
Journal:  Clin Endocrinol (Oxf)       Date:  2001-02       Impact factor: 3.478

3.  Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula.

Authors:  R J Schanler; R J Shulman; C Lau
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

4.  Longitudinal growth of hospitalized very low birth weight infants.

Authors:  R A Ehrenkranz; N Younes; J A Lemons; A A Fanaroff; E F Donovan; L L Wright; V Katsikiotis; J E Tyson; W Oh; S Shankaran; C R Bauer; S B Korones; B J Stoll; D K Stevenson; L A Papile
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

5.  Characterisation of the cytokine inflammatory response in LPS stimulated full-term cord blood.

Authors:  Corrina Powell; Nicolas Orsi; Nigel Simpson; Malcolm Levene
Journal:  J Perinat Med       Date:  2004       Impact factor: 1.901

Review 6.  Strategies for attenuating protein-catabolic responses in the critically ill.

Authors:  T R Ziegler; C Gatzen; D W Wilmore
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

7.  Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

Authors:  O Borrelli; C Bascietto; F Viola; M Bueno de Mesquita; M Barbato; V Mancini; S Bosco; S Cucchiara
Journal:  Dig Liver Dis       Date:  2004-05       Impact factor: 4.088

8.  Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN Study.

Authors:  Julie Bartholomew; Camilia R Martin; Elizabeth Allred; Minghua L Chen; Richard A Ehrenkranz; Olaf Dammann; Alan Leviton
Journal:  Neonatology       Date:  2013-10-30       Impact factor: 4.035

9.  Interleukin-6 polymorphism is associated with chorioamnionitis and neonatal infections in preterm infants.

Authors:  Milla Reiman; Harry Kujari; Eeva Ekholm; Helena Lapinleimu; Liisa Lehtonen; Leena Haataja
Journal:  J Pediatr       Date:  2008-04-03       Impact factor: 4.406

10.  Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates.

Authors:  Hui-Chen Lo; Lon-Yen Tsao; Wen-Yin Hsu; Hsia-Nan Chen; Wai-Kit Yu; Chiu-Yen Chi
Journal:  Nutrition       Date:  2002 Jul-Aug       Impact factor: 4.008

View more
  4 in total

1.  A Randomized Trial of Maternal Docosahexaenoic Acid Supplementation to Reduce Inflammation in Extremely Preterm Infants.

Authors:  Christina J Valentine; Kelly A Dingess; Jeanne Kleiman; Ardythe L Morrow; Lynette K Rogers
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

2.  Acculturation and interleukin (IL)-6 concentrations across pregnancy among Mexican-American women.

Authors:  Laura Scholaske; Claudia Buss; Pathik D Wadhwa; Sonja Entringer
Journal:  Brain Behav Immun       Date:  2018-08-04       Impact factor: 7.217

3.  Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age.

Authors:  Mandy B Belfort; Sara E Ramel; Camilia R Martin; Raina Fichorova; Karl C K Kuban; Timothy Heeren; Rebecca C Fry; T Michael O'Shea
Journal:  J Pediatr       Date:  2021-09-08       Impact factor: 4.406

4.  Association of maternal migrant background with inflammation during pregnancy - Results of a birth cohort study in Germany.

Authors:  Jacob Spallek; Laura Scholaske; Elif Aysimi Duman; Oliver Razum; Sonja Entringer
Journal:  Brain Behav Immun       Date:  2021-06-17       Impact factor: 19.227

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.